PRDX1 (Peroxiredoxin 1) is a member of the peroxiredoxin family of antioxidant proteins that catalyze the reduction of hydrogen peroxide (H₂O₂), organic hydroperoxides, and peroxynitrite. As one of the most abundant cellular proteins, PRDX1 plays critical roles in antioxidant defense, redox signaling, and molecular chaperone activity. Its function is particularly vital in the brain, where oxidative stress is a hallmark of neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/als).[@park2021]
Peroxiredoxins represent an evolutionarily conserved family of peroxidases that were first discovered in yeast and subsequently characterized across all kingdoms of life.[@ishii2010] PRDX1, originally identified as "natural killer-enhancing factor B" (NKEF-B), has emerged as a central player in cellular redox homeostasis and has been extensively studied in the context of neurodegeneration.
PRDX1 (Peroxiredoxin 1) is a member of the peroxiredoxin family of antioxidant proteins that catalyze the reduction of hydrogen peroxide (H₂O₂), organic hydroperoxides, and peroxynitrite. As one of the most abundant cellular proteins, PRDX1 plays critical roles in antioxidant defense, redox signaling, and molecular chaperone activity. Its function is particularly vital in the brain, where oxidative stress is a hallmark of neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/als).[@park2021]
Peroxiredoxins represent an evolutionarily conserved family of peroxidases that were first discovered in yeast and subsequently characterized across all kingdoms of life.[@ishii2010] PRDX1, originally identified as "natural killer-enhancing factor B" (NKEF-B), has emerged as a central player in cellular redox homeostasis and has been extensively studied in the context of neurodegeneration.
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">PRDX1 (Peroxiredoxin 1)</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Peroxiredoxin 1</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[PRDX1](/genes/prdx1)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q06830" target="_blank">Q06830</a></td>
</tr>
<tr>
<td class="label">PDB ID</td>
<td>1XCC, 2ZYL, 1QQ7</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>22 kDa (199 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytosol, Nucleus, extracellular (secreted)</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Peroxiredoxin family (2-Cys typical)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Ubiquitous, highest in brain, liver, kidney</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a>, <a href="/wiki/infection" style="color:#ef9a9a">Infection</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">119 edges</a></td>
</tr>
</table>
PRDX1 is a homodimeric protein with each subunit comprising approximately 199 amino acids. The protein adopts a typical 2-Cys peroxiredoxin fold characterized by:
PRDX1 catalyzes peroxide reduction through a conserved mechanism involving two reactive cysteine residues:
This catalytic cycle allows PRDX1 to neutralize hydrogen peroxide efficiently, preventing oxidative damage to proteins, lipids, and DNA. Unlike catalase or glutathione peroxidase, PRDX1 operates at low peroxide concentrations and plays a central role in redox signaling rather than gross peroxide detoxification.
PRDX1 exhibits remarkable structural plasticity, existing in multiple oligomeric states:
PRDX1 serves as a primary line of defense against oxidative stress in neuronal cells. Its functions include:
Hydrogen peroxide scavenging: PRDX1 reduces H₂O₂ to water with high efficiency (kcat ≈ 10⁵ M⁻¹s⁻¹), protecting neurons from ROS-induced damage. This is particularly important in the brain, which consumes 20% of oxygen yet constitutes only 2% of body weight, making it inherently vulnerable to oxidative stress.
Lipid peroxidation prevention: By reducing organic hydroperoxides (e.g., lipid hydroperoxides), PRDX1 protects neuronal membranes from peroxidation damage that contributes to neurodegeneration.
DNA protection: PRDX1 localizes to the nucleus and protects DNA from oxidative damage, important for neuronal genomic stability.
Beyond simple antioxidant function, PRDX1 participates in sophisticated redox signaling pathways:
H₂O₂ as a second messenger: At physiological concentrations, H₂O₂ acts as a signaling molecule regulating various processes including cell proliferation, differentiation, and stress responses. PRDX1 modulates H₂O₂ levels to ensure appropriate signaling while preventing damage.
Interaction with transcription factors: PRDX1 interacts with and regulates key transcription factors including:
Under conditions of severe oxidative stress, PRDX1 transitions from an enzyme to a molecular chaperone:
PRDX1 plays complex roles in regulating apoptosis and necrosis:
Anti-apoptotic function: PRDX1 inhibits various apoptotic pathways:
PRDX1 is profoundly affected in [Alzheimer's disease](/diseases/alzheimers-disease), with both expression changes and post-translational modifications observed:
Expression alterations: Multiple studies have documented increased PRDX1 expression in AD brain, representing a compensatory response to heightened oxidative stress. However, this elevated PRDX1 becomes progressively inactivated through hyperoxidation, reducing its protective capacity.
Oxidative modification: Cumming et al. (2004) first demonstrated that PRDX1 is oxidatively modified in AD brain, with increased levels of the disulfide-bonded form indicating functional impairment.
Relationship to Aβ pathology: PRDX1 interacts with amyloid-beta (Aβ) peptides:
In [Parkinson's disease](/diseases/parkinsons-disease), PRDX1 plays critical protective roles, particularly in dopaminergic neurons:
Protective function in dopaminergic neurons: Yang et al. (2009) demonstrated that PRDX1 protects dopaminergic neurons from oxidative stress-induced cell death through multiple mechanisms:
Therapeutic development: PRDX1-based therapeutics for PD include:
In [ALS](/diseases/als), PRDX1 alterations contribute to disease progression:
Oxidative stress marker: Elevated PRDX1 levels in CSF and brain tissue serve as biomarkers of oxidative stress in ALS.
Mutual TDP-43 relationship: The RNA-binding protein TDP-43, which forms characteristic inclusions in ALS, may regulate PRDX1 expression. Conversely, PRDX1 deficiency accelerates TDP-43 pathology in model systems.
SOD1 interactions: In SOD1-linked familial ALS, PRDX1 may interact with mutant SOD1 aggregates, potentially contributing to the oxidative stress burden.
Therapeutic targeting: Strategies to enhance PRDX1 function in ALS include:
Huntington's disease: PRDX1 expression is altered in HD brain, with implications for mitochondrial function and mutant huntingtin aggregation.
Multiple sclerosis: PRDX1 serves as both a biomarker and therapeutic target in demyelinating diseases.
Stroke and traumatic brain injury: PRDX1 is upregulated in response to acute brain injury, where it limits oxidative damage.
Given its central role in oxidative stress defense, PRDX1 represents an attractive therapeutic target:
Upregulation strategies:
Blood-brain barrier: Therapeutic delivery of PRDX1 to the CNS remains challenging; novel approaches including intranasal delivery and BBB-modulating agents are under investigation.
Optimal dosing: Too much PRDX1 activity may interfere with physiological redox signaling; precise dosing regimens are needed.
Biomarker development: PRDX1 levels in CSF or blood may serve as biomarkers for patient selection and treatment response.
PRDX1 expression is regulated at the transcriptional level by multiple factors:
PRDX1 is also regulated at the post-transcriptional level:
PRDX1 interacts with numerous proteins, forming a network relevant to neurodegeneration:
| Partner | Interaction Type | Functional Consequence |
|---------|------------------|------------------------|
| Thioredoxin (TXN) | Substrate | Enzyme reduction/regeneration |
| Thioredoxin reductase | Indirect | Provides reducing equivalents |
| ASK1 | Inhibition | Blocks pro-apoptotic signaling |
| NF-κB (p65) | Inhibition | Reduces inflammation |
| p53 | Stabilization | Modulates DNA damage response |
| α-Synuclein | Binding | May reduce aggregation |
| TDP-43 | Interaction | Modifies ALS pathology |
PRDX1 participates in several critical signaling pathways:
Antioxidant response: Nrf2 → PRDX1 → cellular defense genes Apoptosis regulation: PRDX1 → ASK1/JNK → cell survival Inflammation: PRDX1 → NF-κB → pro-inflammatory cytokines Redox signaling: ROS → PRDX1 oxidation → adaptive response
PRDX1-deficient mice exhibit:
PRDX1 transgenic mice show:
PRDX1 levels in CSF serve as:
Peripheral PRDX1 measurements:
Several aspects of PRDX1 biology remain incompletely understood:
PRDX1 stands as a critical defender against oxidative stress in the nervous system, with protective roles in multiple neurodegenerative diseases. Its dual function as a peroxidase and molecular chaperone makes it uniquely positioned to combat the proteostatic and oxidative stress that characterize Alzheimer's, Parkinson's, and related conditions. Understanding and targeting PRDX1 offers promising therapeutic opportunities, though significant challenges remain in translating basic research into clinical applications.
As the field progresses, PRDX1-based therapies may become part of combination approaches that address multiple pathological mechanisms simultaneously—an essential strategy given the complex nature of neurodegenerative diseases.